|
|
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121 USA
phone:(858) 452-0370
fax:(858) 677-9975
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.triusrx.com
|
|
|
|
 |
| Summary Description |
| Antibiotics for life-threatening bacterial infections. |
|
| Management |
| Jeffrey Stein, Ph.D, President & Chief Executive Officer; John Finn, Ph.D., Chief Scientific Officer; Kenneth Bartizal, Ph.D., Chief Development Officer; Philippe Prokocimer, M.D., Chief Medical Officer; Karen E. Potts, Ph.D., Vice President of Regulatory Affairs; John P. Schmid, Chief Financial Officer; Karen Joy Shaw, Ph.D., V. P. of Biology; Neil Abdollahian, Senior Director of Business Development |
| |
|
|
|
|
|
| Keywords |
| antibiotics, bacteria, bacterial infections, infections, mrsa |
|
|
|
| Description |
|
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. We are preparing to initiate Phase 3 clinical trials for torezolid phosphate, an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus, or MRSA. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members